Literature DB >> 11451980

Bunionette.

M Koti1, N Maffulli.   

Abstract

The bunionette, or tailor's bunion, is a painful osseous prominence on the lateral aspect of the head of the fifth metatarsal. This prominence occurs in many individuals but seldom causes symptoms. Orthotic devices may be useful if a symptomatic bunionette results from excessive pronation of the subtalar joint. Operative management to decrease the width of the foot and the osseous prominence is indicated when nonoperative treatment can no longer control symptoms and when the patient has special demands, particularly in sports. A proximal osteotomy is able to correct most deformities. A distal osteotomy is recommended if medial translation of the head for one-third of the width of the metatarsal shaft produces a normal fourth-fifth intermetatarsal angle.

Entities:  

Mesh:

Year:  2001        PMID: 11451980     DOI: 10.2106/00004623-200107000-00016

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  4 in total

Review 1.  Minimally invasive bunionette correction.

Authors:  G A Morawe; M H T Schmieschek
Journal:  Oper Orthop Traumatol       Date:  2018-04-27       Impact factor: 1.154

2.  Degree of Impact of Tailor's Bunion on Quality of Life: A Case-Control Study.

Authors:  Victoria Mazoteras-Pardo; Ricardo Becerro-de-Bengoa-Vallejo; Marta Losa-Iglesias; Patricia Palomo-López; Daniel López-López; César Calvo-Lobo; Carlos Romero-Morales; Israel Casado-Hernández
Journal:  Int J Environ Res Public Health       Date:  2021-01-16       Impact factor: 3.390

3.  Symptomatic Bunionette Treated with Sliding Oblique Metatarsal Osteotomy-Case Series.

Authors:  Yu-Ting Shen; Peng-Ju Huang; Shu-Jung Chen; Shun-Min Chang
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

4.  Biphalangeal/triphalangeal fifth toe and impact in the pathology of the fifth ray.

Authors:  Jose Gallart; David González; Jose Valero; Javier Deus; Pedro Serrano; Manuel Lahoz
Journal:  BMC Musculoskelet Disord       Date:  2014-09-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.